View Older Stories View More Recent Stories
-
Citi Maintains a 'Buy' on NVIDIA Corp (NVDA); Removes From Top Picks Live List
-
Citi Analyst Issues Positive Comments on the Semiconductor Sector: Intel & NVIDIA Remain on 'Top Picks Live' List
-
Citi Reiterates a 'Buy' on NVIDIA Corp (NVDA); Quarter Tracking Above Consensus
-
Notable Analyst Rating Changes 02/25: ESV, FARO, TSL/YGE/SOL/STP Upgraded; PALM, FITB, GME, BBI, SBIB Downgraded
-
Top 10 News Items 2/16-2/19: Fed Surprises the Street with a Hike to the Discount Rate, Simon Property Offers to Purchase General Growth, PPI Comes in Hotter, CPI Comes in Cooler
-
Notable Analyst Rating Changes of the Day 02/11: SOL, PALM, CPA, NVDA, ENER, HUBG Upgraded; SNI, FE, DF, BSX Downgraded
-
Top 10 News Items 12/14-12/18: Citi Stumbles to Repay TARP, Abu Dhabi Extends $10B Bailout to Dubai, Exxon Acquires XTO in $41B Deal
-
Notable Analyst Rating Changes for 11/20: STP, HES, DDS, LINTA Upgraded; PFG, CSX, VRSN, BOFL, D, ADCT Downgraded
-
NVIDIA (NVDA) Shines In Q3 (Update)
-
Notable Analyst Rating Changes 10/28: TXN, MOT, TGT, WYNN, ILMN Upgraded; APOL, SNDK, NVDA, X, VCLK Downgraded
-
David Moenning's Daily State of the Markets: Subtle, Yet Effective
-
Top 10 News Items 8/3-8/7: Job Losses Are Slowing; Earnings Season Is Concluding; S&P Closed Above 1,000
-
Notable Analyst Rating Changes 7/29: MCK, CPB, COH, ROK, MEE Upgraded; MS, MGM, AFL, WDC, PERY, LRY Downgraded
-
Active equity option families in first 30 minutes of trading according to Track Data are: C STT NVDA AAPL
-
Citi Reiterates a 'Buy' on NVIDIA Corp (NVDA), Adds to 'Top Picks Live' List
-
David Moenning's Daily State of the Markets: 5/8
-
After-Hours Movers 5/7: ARP, FITB, FSYS, MNTG, MEMS, XOMA Higher; CROX, RMTR, GNW, BAGL, ERII, JSDA Lower
-
David Moenning's Daily State of the Markets: 4/28
-
Citi Maintains a 'Buy' on NVIDIA (NVDA); Advocate "Buy The Dips" Strategy on Pullbacks
-
Top 10 News Items 1/9-1/13: Geithner Unveils Financial Rescue Plan; Big Bank Execs BBQ'ed on Capitol Hill; Stimulus Package Close to Final Approval
-
Morning Movers 1/13: ZymoGenetics (ZGEN) Up On Bristol-Myers Deal; Lexmark (LXK) Down On Guidance
-
Citi Remains Positive on Semiconductor Stocks, Reiterates 'Buy the Dips' Not 'Sell the Rallies'
-
Citi Issues Mid-Quarter Update on Semiconductors - Reduces Estimates on Nine Companies
-
Citi Reiterates a 'Buy' Rating on NVIDIA (NVDA)
-
David Moenning’s Daily State of the Markets: 11/03
-
Notable Analyst Rating Changes 11/03: WMT, BIIB, NVDA, SLB Upgraded; SSCC, DO, HAL, PHM Downgraded
-
Citi Upgrades NVIDIA Corp (NVDA) to Buy
-
Mornings Movers 10/23: Global Sell Off Kills Financials, Tech, Solar (NCC, GS, GOOG, FSLR)
-
David Moenning's Daily State of the Markets: 10/14
-
Pre-Open Movers 9/19: Financials In Rocket-Mode On Mortgage Plan and Short Selling Ban
-
Notable Analyst Rating Changes 9/11: NVS, TSN, ALB Upgraded; LEH, NVDA, RAI, KNXA Downgraded
-
Pre-Open Movers 9/11: Lehman (LEH) In Free-Fall On Worries, Other I-Banks Follow (MER, GS, MS, C); CSX (CSX) Up on Raised Guidance
-
Citi Maintains 'Neutral' Rating on NVIDIA (NVDA), Lowers Price Target to $15
-
Notable Analyst Rating Changes 7/3: LLL, ACI, BTU, AA Upgraded; HNT, AET, NVDA Downgraded
-
Notable Analyst Rating Changes 7/1: SIRI, AXP, NVDA, CTAS Upgraded; FO, ALTR, RBN Downgraded
-
Notable Analyst Rating Changes 5/28: UPS, FTO, WBMD, NVDA Upgraded; OVTI, EXC, RYAAY Downgraded
-
What's Steven Cohen's SAC Capital Buying? A Few Banks Among Other Things (BK, C)
-
David Moenning's Daily State of the Markets: 5/8
-
Notable Analyst Rating Changes 5/9: ATVI, NVDA, HES Upgraded; CELG, PEC, DRS Downgraded
-
Pre-Open Movers 5/9: Circuit City (CC) Up on Strategic Options News; Cogent Comm (CCOI) Sinks on Results/Guidance
-
Citi Maintains 'Hold' Rating on NVIDIA (NVDA)
-
Notable Analyst Rating Changes 3/3: KSS, MELI, CEPH, LULU Upgraded; APOL, F, ISLE, TMA Downgraded
-
David Moenning's Daily State of the Markets: 2/14
-
David Moenning’s Daily State of the Markets: 01/15
-
Pre-Open Movers: MoneyGram (MGI) Sinks On Investment Losses, Manatron (MANA), Lifecore Biomedical (LCBM) Up on Buyouts

